2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

Portefølje Naturvitenskap og teknologi ikon

Forskningssystemet

Portefølje Humaniora og samfunnsvitenskap ikon

Banebrytende forskning

Portefølje Samisk ikon

Samisk samfunn og kultur

Portefølje Demokrati, styring og fornyelse ikon

Demokrati og global utvikling

Portefølje Velferd, kultur og samfunn ikon

Velferd og utdanning

Portefølje Helse ikon

Helse

Portefølje Klima- og polarforskning ikon

Klima og miljø

Portefølje Landbasert mat, miljø og bioressurser ikon

Mat og bioressurser

Portefølje Energi, transport og lavutslipp ikon

Energi og transport

Portefølje Muliggjørende teknologier ikon

Muliggjørende teknologier

Portefølje Industri og tjenestenæringer ikon

Innovasjon

LTP2 Klima, miljø og miljøvennlig energi ikon

Klima, miljø og energi

LTP2 Samfunnssikkerhet og samhørighet ikon

Samfunnstryggleik og beredskap

LTP2 Fornyelse i offentlig sektor ikon

Velferdstjenester

Forsidebilde

Marin ikon

Petroleum og mineraler

LTP Hav ikon

Hav og kyst

LTP2 Muliggjørende og industrielle teknologier ikon

Mogleggjerande industrielle teknologiar

Tillit og fellesskap

LTP2 Utvikle fagmiljøer av fremragende kvalitet

Høg kvalitet og tilgjengeleg

LTP2 Styrket konkurransekraft og innovasjonsevne ikon

Sterkare konkurransekraft og innovasjonsevne

LTP3 Helse

Et innovativt næringsliv ikon

Styrket konkurransekraft og innovasjonsevne

Portefolje Petroleum Ikon

Portefølje Hav ikon

Portefølje Utdanning og kompetanse ikon

Portefølje Global utvikling og internasjonale relasjoner ikon

Portefølje Livsvitenskap ikon

Forsidebilde optimalisert

project-bank-technical

Muliggjørende teknologier bakgrunn

Marin bakgrunnsbilde

Statistikk

Prosjektbanken presenterer statistikk og informasjon om prosjekter med finansiering fra Forskningsrådet fra 2004. Statistikken er fordelt på blant annet tema, år, geografi og organisasjon. Prosjektbanken gir også detaljert informasjon om de enkelte prosjektene.

...eller se sammendrag og annen informasjon om prosjektene i utvalget ditt

Alle porteføljestyrer

En god beskrivelse av denne siden for søkemotoroptimalisering

Forside

Hvordan tildelingene fordeler seg på institusjoner, fylker, fagområder o.l....

Her er noen eksempler på søk du kan gjøre i Prosjektbanken

Alle langtidsplanmål

Veiledning: Hvordan bruke Prosjektbanken.no

Om Fritekstsøk

Ingen populærvitenskapelig framstilling tilgjengelig


Prosjektet med prosjektnummer {{project number}} ble ikke funnet

Teknisk beskrivelse

Oisann, her gikk noe galt. Kan du prøve å laste siden på nytt?  Dersom feilen vedvarer, vennligst kontakt oss.         

Se statistikk relatert til dette langtidsplanmålet

Se prosjekter relatert til dette langtidsplanmålet

knyttet til dette LTP-målet har blitt tildelt penger

har blitt tildelt til prosjekter knyttet til dette LTP-målet

har blitt tildelt til prosjekter knyttet til denne porteføljen

knyttet til denne porteføljen har blitt tildelt penger

Om Prosjektbanken

Kunnskapsdepartement

Ukjent

Klima- og miljødepar

Nærings- og fiskerid

Utenriksdepartemente

Energidepartementet

Landbruks- og matdep

Olje- og energidepar

Teknologi

Matematikk og naturvitenskap

Medisin og helsefag

Oslo

LTP3 Styrket konkurransekraft og innovasjonsevne

LTP3 Et kunnskapsintensivt næringsliv i hele landet

LTP3 Høy kvalitet og tilgjengelighet

LTP3 Fagmiljøer og talenter

LTP3 Rettede internasjonaliseringstiltak

LTP3 Muliggjørende og industrielle teknologier

LTP3 Nano-, bioteknologi og teknologikonvergens

Næringsliv

UoH-sektor

Portefølje Forskningssystemet

Portefølje Muliggjørende teknologier

Portefølje Banebrytende forskning

Portefølje Helse

Portefølje Innovasjon

Nettverkstiltak

Frittstående prosjekter

Koordinerings- og støtteaktivitet

Ingen søknadstype

Internasjonalisering

Anvendt forskning

Naturmangfold og miljø

Bioteknologi

Miljøteknologi

Utviklingsarbeid

Bransjer og næringer

Politikk- og forvaltningsområder

Grunnforskning

Bilingual Experiences, Cognitive Ageing and underlying Mechanisms

The goal of the Bilingual Experiences, Cognitive Ageing and underlying Mechanisms (BECAME) project is to examine the functional neuroplastic mechanisms underlying mitigatory effects of bilingual experience on age-related cognitive decline. While evidence is available for structural brain changes supporting bilingualism-induced effects on cognitive aging (CA), functional mechanisms underlying such effects are not yet well understood. BECAME aims to fill this gap by investigating the trajectory of bilingualism-induced functional neuroplasticity across the adult lifespan (ages 18-85), crucially adopting an individual differences approach related to measurable degree of bilingual engagement. Importantly, although such benefits are thought to be rooted early in the lifespan, evidence for the timeframe and conditions of their early emergence is scarce. The choice of including the whole adult lifespan allows us to investigate these mechanisms and their emergence more directly from a lifespan perspective. I combine behavioral testing with brain recordings via electroencephalography (EEG). EEG is widely used in cognitive neuroscience to assess brain activity and the degree of communication between brain regions (functional connectivity) in response to stimuli and at rest. Combining behavioral and EEG modalities will allow me to test bilingualism’s effect on functional connectivity, as well as its consequences for functional efficiency, the minimum required neural activation to successfully perform a task. This will enable a detailed, evidence-based account of the protective effects observed in older-aged bilinguals, and how they are built from earlier life stages. By illuminating the relationship between multilingualism and resulting neurocognitive adaptations, BECAME will enable to capitalize on it as a health initiative, with manifold societal implications and the potential to be translated into actionable policies exploiting multilingualism to ameliorate effects of CA.

BOLD MINDS aspires to enhance the understanding of vulnerability factors underlying the emergence of borderline personality disorder (BPD), with an ultimate aim of increasing the potential for young individuals to receive early, evidence-based help when their mental health is at risk. BOLD MINDS will achieve this by investigating whether disruptions in two aspects of autobiographical memory (AM), narrative identity (NI) and involuntary AM (IAM), are associated with BPD features and problem behaviours in adolescents concurrently and over time. In doing so, BOLD MINDS will strengthen the understanding of mechanisms underlying the emergence of BPD in adolescence and lay a groundwork for developing evidence-based early interventions for BPD. While currently limited, the study of AM in this field is essential for two reasons. Firstly, because the aspects of AM under investigation, NI and IAM, are known to be involved in identity formation and emotion regulation which represent two key psychological processes that are disrupted in adults with BPD and are linked to problem behaviours such as self-harm and suicidality. Secondly, because promising research is emerging on the use of AM targets in the treatment of emotional disorder in adults, and provides a strong model for future treatment development with vulnerable adolescents. In addition, this timely research program aligns with calls from international organizations to prioritize early interventions to promote adolescent mental health. BOLD MINDS will adopt and adapt state-of-the-art ecological momentary assessment and analytical techniques and work at the crossroads of clinical and cognitive psychological perspectives, allowing for a multidimensional approach to understanding BPD vulnerability. Training-through-research and formalized training of the experienced researcher will prepare her for a permanent academic position and the founding of her own research lab specializing in AM and early interventions for BPD.

Borderline Personality Disorder: Memory and Identity in Adolescence

WHeelchair Activity Monitoring project (WHAM)

Wheelchair users (WCU) are three to five times more inactive than the general population, leading to a high risk of developing preventable secondary conditions. Although physical activity (PA) guidelines have been specifically developed for WCU, we lack systematic approaches to implement them in practice, as well as valid algorithms to monitor PA change in WCU through sensor-based solutions. Accordingly, the overall scientific aim of the WHeelchair Activity Monitoring project (WHAM) is to advance PA research and practice in WCU by developing valid digital markers for monitoring of and providing feedback on PA, paving the way for implementation and intervention. I will accomplish this through combining the complementary research fields of 1) behavioural intervention studies focusing on increasing PA in WCU (core competence University of British Columbia, UBC; outgoing phase) and 2) sensor-based PA monitoring (core competence Norwegian University of Science and Technology, NTNU; returning phase – consolidated by non-academic placement at Maastricht Instruments, which develop research prototypes including PA monitors). WHAM’s scientific aim is achieved through three objectives: 1) Measure the effect of a pragmatic exercise intervention trial on self-reported physical activity levels and cardio-respiratory fitness, 2) Develop valid algorithms for tracking PA markers in WCU, and 3) Co-create a framework that outlines how PA can be conjointly monitored and provided feedback on in WCU. This fellowship will enable me to become established as an internationally recognized researcher in the field of “physical activity and disability”, while bringing together ongoing national disjointed research activities in this field. Altogether, my overall ambition is to contribute to reducing inequalities in daily-life participation among WCU compared to the rest of the population.

Despites dental pulp capping materials should meet the certain requirements, the available materials have one or more shortcomings—poor biocompatibility and rheological properties, fail to maintain pulp vitality and to simulate reparative dentine formation and expensive etc. Mineral trioxide aggregate (MTA) is widely used material because of its beneficial properties. However, its composition bismuth oxide, which is suspectable to toxicity, has an impact on rheological properties. This emphasizes the necessity of looking for inexpensive alternatives to materials that meet the specifications. This project's goal and novelty are to investigate the potential processing of the dental pulp capping cement, which is made of strontium silicate (SrSiO3), strontium fluoride (SrF2), piezoelectric material (PZM) and tricalcium silicate (Ca3O5Si) and its rheological properties and hemocompatibility. Because SrSiO3, SrF2, PZM and Ca3O5Si have the promising properties. This project's work packages are split into four categories based on the interdisciplinary approach since it involves the synthesis and characterization of PZM, the processing and characterization of cement, the identification of rheological parameters utilizing ISO standardizations, and hemocompatibility, and acquiring new transferrable skills. Additionally, the interactions among the selected compounds will be determined. The scientific impact of this project is comprehending the physical properties and the immune system's response to evaluate the cement's suitability as a replacement for existing materials, as well as resulting in further uses in dentistry and medicine. The societal impact is providing millions of patients in Europe with predictable and outstanding treatment outcomes each year to maintain pulp vitality and health. Eventually, it will ease the financial load on millions of patients who need dental care, will be avoiding inflated medical expenses and misuse of the patent (economic impact).

SrSiO3-based Dental Pulp Capping Cement

Longitudinal Investigation of Visual and Numerical Perception in Preterm and Full-term Infants

The number of preterm births is on the rise -now more than 1 in 10 babies- and being born preterm is associated with having difficulties in two very important and related cognitive skills that we rely on daily: numerical and visual perception. However, a knowledge gap exists on neural and behavioural associations of numerical and visual perception in full-term and preterm infants. PrePER aims to uncover the underlying neural signatures of the cognitive dysfunctions that preterm infants might display in the first year of their lives and the role of parent-baby interaction to predict preterm infants that are at risk of developing these cognitive difficulties in the second year of their lives. The purpose is to establish criteria to identify infants (especially preterm) at-risk of having cognitive difficulties in numerical and visual perception. Shedding light on normal and impaired cognitive functions in infancy is an essential stepping stone that will pave the way for early diagnostic tools and interventions that would correct the cognitive dysfunctions more efficiently while the brain is still developing. The activities in PrePER will lead to original and innovative outcomes that are beneficial for four parties: 1) Scientific communities will be interested in the results as the ambitious research objectives address questions that have not been asked before. 2) Parents of preterm infants, health-care providers, and policy makers will be interested in the results as the overall aim is to establish criteria to identify infants at-risk of having cognitive-developmental difficulties in the first year of their lives. 3) The researcher will be accelerating her career progression as the training objectives meet her specific needs. 4) The supervisor will be enlarging her research interest and network as the research objectives include a topic within the researcher’s expertise.

AQUASERV – RESEARCH INFRASTRUCTURE SERVICES FOR SUSTAINABLE AQUACULTURE, FISHERIES AND THE BLUE ECONOMY

The overarching objectives of AQUASERV are to bring together, enhance, integrate and customise RI capacities (including facilities, instruments and expertise) and through the provision of transnational access (on-site or remote) and/or virtual access, to significantly further scientific advance and promote and facilitate the implementation of European Common Fisheries Policy, the Farm to Fork Strategy, the Sustainable Blue Economy and the European Green Deal.   AQUASERV will achieve these objectives by offering scientists from academia and business remote and on-site transnational (TA) and virtual (VA) access to an advanced set of European research infrastructures and its nodes related to research and management of marine and freshwater biological resources, food and biotechnology. These include the European Marine Biological Resource Centre ERIC (EMBRC), the Analysis and Experimentation on Ecosystems ERIC, The Aquaculture for Excellence for Aquaculture in Fish (Aquaexcel), and the Infrastructure for Promoting Metrology in Food and Nutrition (METROFOOD), as well as the International Council for Exploration of the Sea, both a service provider and stakeholder. It also includes the Research Infrastructure for Science and Innovation Policy Studies (RISIS) to bring contributions from the social sciences and to bring results nearer to policy makers ensuring societal impact.   To enhance, integrate and customise RI capacities, collaboration between partners and new pipelines to meet the objectives of the project will be developed during the first 3 years and will make available  to users.  To ensure these capacities will not be lost, a sustainability work package involving stakeholders will address the project legacy.    To maximize impact, AQUASERV will build a communication network among the partnership and develop a dissemination and outreach programme. Furthermore, an advanced training programme will be developed to capture future users and will be updated during the p

IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN

EU-OPENSCREEN (EU-OS), the distributed European Research Infrastructure for Chemical Biology and early drug discovery, provides world-class services in high-throughput compound screening and medicinal chemistry to users from academia and industry. As one of the largest open-access initiative globally, EU-OPENSCREEN plays an increasingly important role in facilitating early stage drug discovery in Europe. It recently integrated fragment-based drug discovery and chemoproteomics as two new services, but the increasing complexity of modern drug discovery projects requires an even more comprehensive portfolio and integration of emerging technologies. To ensure that EU-OS continues to offer a comprehensive suite of relevant services and support a growing user community to conduct forefront research, IMPULSE will develop, validate and integrate new services in AI/ML, new chemical modalities, and innovative disease-relevant cell models combined with CRISPR-Cas9/RNAi-based genetic screening. IMPULSE will work towards the implementation of common operational and data standards to increase data reproducibility and FAIRness. Bespoke outreach and training activities will raise awareness among key user groups of its new services and advance operational excellence and reproducibility in pre-clinical drug discovery. New models for pre-competitive drug discovery with industry or charities, and growing ERIC member community will reinforce the sustainability and accessibility of EU-OPENSCREEN.

Strengthening resilience and mental wellbeing through the Support4Resilience toolbox for leaders in elderly care

European elderly care experiences labor shortages, lack of qualified workers and a mismatch between capacity and demands, causing stress, burnout, and reduced mental wellbeing among healthcare workers and informal caregivers. Leaders are crucial in promoting supportive working conditions but lack research-based measures to act upon these challenges.  Support4Resilience (S4R) will develop, implement, and evaluate a research-based Toolbox to support healthcare leaders in improving healthcare workers’ and informal caregivers’ resilience and mental wellbeing in elderly care. S4R will identify resilience and mental wellbeing factors among healthcare workers and informal caregivers; explore their perspectives and needs; develop new theory on the relationship between individual and organizational resilience, and mental wellbeing; and develop recommendations and cost-effective interventions. The Toolbox with tailormade resources for policy and practical use will be available through an open access S4R Resource Bank.  The S4R Toolbox includes three main tools: 1) Mapping and identification, 2) Reflection and education, and 3) Reorganization. Measures are initiated at the organizational level and effects on mental wellbeing and resilience transpire at the frontline of elderly care. The Toolbox covers different situational contexts, types of healthcare providers and health system levels. Elderly care settings in six European countries will implement and evaluate the Toolbox through a process evaluation, effectiveness evaluation, and cost-effectiveness evaluation.   S4R provides policymakers, decisions-makers and leaders with solutions for taking action to solve specific risks for healthcare workers’ and informal caregivers’ resilience and mental wellbeing. Thus, pertinent to the work programme, S4R will support the development of resilient health systems in European elderly care through improved leadership capabilities, governance structures, and adaptive capacities.

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

The NOVO project will address a fundamental issue in proton radiotherapy (PT) of cancer, namely the lack of real-time dose verification (RDV) that significantly limits the potential of PT due to uncertainties in the precise delivery of the prescribed dose. In the NOVO project, we will develop the first proof-of-concept of an RDV technology adaptable to any PT treatment and bring the concept to TRL 4 by also considering integration into the PT clinical workflow. The RDV technology will be pivotal for enabling the next generation of adaptive PT therapy, i.e., dose-guided real-time adaptive therapy. Real-time measurement of the dose to targeted and non-targeted tissues will be the key to truly empower patient-centered, personalized cancer treatment, important to improve curation and quality-of-life post-treatment. As a high-risk/high-gain project, NOVO aims at a first-of-its-kind RDV technology through the unique synergy between (1) cutting-edge, inexpensive organic scintillator technology that can detect secondary radiation during treatment for non-invasive measurements, (2) novel and fast image reconstruction, artificial intelligence (AI)-accelerated models and AI-enhanced image reconstruction to allow simultaneous detection of multiple radiation species and tissue compositional analysis, (3) tumor-tracking and imaging of tissue radio-sensitivity based on oxygen levels, (4) intelligent automation of decision-making schemes for real-time dose-guided adaptive therapy. The project will essentially open a new era in PT that enables curing more cancer patients and reducing toxicity from treatment. The NOVO consortium covers the entire value chain of RDV development (technology providers, theory and modelling, technology integration and PT clinics) and optimally engages nuclear, medical, and high-energy physicists, chemists, mathematicians, computer scientists, oncologists, biologists, as well as European PT centers.  

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photodynamic therapy (PDT) show limited efficacies due to the low penetration of light into tissue. Proton radiotherapy can reach deep-lying disease through therapeutic energy deposition in a spatially confined region called Bragg peak. Current neutron-based therapies, like Boron Neutron Capture Therapy (BNCT), have sufficient penetration depth but lack cancer specificity. In NuCapCure, we propose to 'hijack' intracellular biosynthetic pathways and use them to produce custom-made drugs that will facilitate two genuinely new cancer treatments: i) "NuCapCure Proton", combining proton radiotherapy, protondynamic therapy through PS proton activation, and proton capture therapy (BPCT) through three produced alpha particles; and ii) "NuCapCure neutron", combining GBM specific BNCT and PS neutron activation as demonstrated in our FET-open project FRINGE. The main scientific breakthroughs of NuCapCure will be to demonstrate the custom production of novel compounds through native intracellular biosynthesis but also to establish experimental proof-of-principle, both in vitro and in vivo, of the proposed two novel therapies. Our highly interdisciplinary project team comprises world-renowned experts from a unique combination of disciplines: proton and neutron physics, synthetic chemistry, photochemistry, photobiology, radiobiology, medical physics, nuclear reactor and particle accelerator technology and radio-oncology to lay the foundations for novel, targeted and curative therapies against currently fatal cancer indications like GBM.

Midlene fra FRIMED-Klinisk medisin og folkehelse fordelt på år

Midlene fra FRIMED-Klinisk medisin og folkehelse fordelt på fylker

Midlene fra FRIMED-Klinisk medisin og folkehelse fordelt på fagområde

Professor

Persistent negative thinking about oneself is considered as pathological. Beck incorporated schematic negative thinking as a core element in his model of depression. However, the conceptual status of this phenomenon is less clear. While most stress the ne gative content of thinking, we propose to focus on the process. We approach negative thinking as a mental habit, and thus measure it with a newly developed measure, the Self-Report Habit Index of negative self-thinking (SRHI). We assume that by focusing o n the habitual process of negative thinking, rather than the negative content of thoughts per se, we are able to make theoretical and practical advancements. Three theoretical questions are addressed. Negative habitual self-thinking will be tested as a ma rker of cognitive vulnerability to depression. It will be tested whether the self-concept may form a trigger of habitual negative self-thinking. We will test the depressive realism hypothesis, i.e., whether negative habitual thinking is associated with th e absence of a positivity bias or the presence of a negativity bias in self-thinking. Finally, the SRHI will be tested as a monitoring device in therapy.

Negative thinking as dysfunctional habit

The aDDRess Innovaiting Training Network is focused on providing training for individual PhD students in research on DNA damage and DNA repair ranges from characterising genes and pathways involved in the maintenance of DNA structure in healthy cells to analysing the physiological, cellular and molecular responses that occur upon DNA damage and molecular analysis of diseases associated with DNA damage. Our training program is of direct relevance to the call: we will prepare a proposal focused on training of Early Stage Researchers (ESRs) delivered via interdisciplinary networking and arranging joints doctorates. We plan to enrol 12 ESRs with a scientific focus on the functional role of DNA damage response and DNA repair mechanisms in development and disease. Each ESR will have an individual research project, which will be combined with shorter research trainings in the Partner organisations, attendance of networking events and courses. We will create an excellent European research network for ESRs training in key technologies, that will enable them to achieve their scientific goals and enhance their future employment prospects.

Innovative Training Network - DNA damage responses in Development and Disease, aDDRess

Project to be established: Developing a novel diagnostic tool for assessing DNA repair capability.
DNA repair is a crucially important player in preventing mutations and therefore cancer. It is also important as a factor in determining individual patients ' response to cancer therapy. We will develop a diagnostic tool for DNA repair assessment based on novel, high throughput, miniaturized, automated techniques. Till now, such a tool has not been available, since DNA repair assays have been very labour-inte nsive. 
Our tool will be based on the comet assay - a sensitive, well-established method for measuring DNA breaks. Electrophoresis of lysed, gel-embedded nuclei gives comet-like fluorescent images in which the relative tail fluorescence indicates the leve l of DNA damage. We have developed high throughput versions of the assay, and now plan to adapt these for measuring repair, using three distinct approaches: a cellular repair assay, in which cells are treated with DNA damaging agent, incubated, and remain ing damage measured at intervals; an in vitro assay, based on incubation of cell extract with DNA substrate containing specific lesions; and an assay for accumulated repair Intermediates when repair synthesis is blocked.
The new tool will be validated aga inst existing methods, and applied in a pilot clinical study. Our aim is that the method should become available as a standard tool for use in hospitals, and also in human biomonitoring studies, for example monitoring DNA repair in subjects occupationally  exposed to DNA damaging agents. Another possible application is in personalising healthcare.
Challenges: Defining role of partners, allocating workpackages, agreeing finances. R&D challenges: Miniaturising the repair assay to make use of small numbers of  cells; applying robotic technology to automate the assay; devising a rapid scoring method; validating the new methods in clinical studies.

High Throughput Estimation of DNA Repair Capability

A compact comet assay for versatile biomedical testing

Novel and emerging contaminants in Europe: Sources, occurrence, fate and impact for humans and the environment.

Molecular epidemiology is a discipline in which the methods of molecular biology are applied to human populations. We have developed a battery of methods for measuring diverse kinds of DNA damage, and capacities for DNA repair, in human lymphocytes. These  biomarkers allow us to investigate the impact of environmental factors, lifestyle, nutrition, sex and genetic polymorphisms on genomic instability, which is assumed to be causally related to aging and cancer. First, we need to establish mean baseline val ues for the various biomarkers, and the range found in a normal healthy population. To this end, we have collected and stored samples from about 300 subjects in the 'Norwegian Baseline Study'. These samples await analysis. The Yggdrasil scholar will learn  the necessary techniques, carry out certain method development (to optimise the DNA repair assays), and then analyse as many stored samples as possible in the time available. The ultimate aim is two-fold: first, to investigate associations between the pa rameters we measure and the anthropometric and nutritional information gathered by colleagues involved in this study; and second, to contribute to the database being established under ComNet, a new project to validate the comet assay as a biomonitoring to ol, and to establish reference values of biomarkers for future comparisons.

Analysing DNA damage and repair in human population groups- Mobile researcher: Olena Bilyk, Ukraine

There is an increasing awareness of the potential risks from man-made chemicals to the environment and health. Regulations are coming into force that require rigorous testing of all chemicals above a certain level of usage. We will create a network of exp erts to provide research expertise and to apply selected state-of-the-art-assays in the field of environmental genotoxicity. Such assays are needed for basic research into genome damage and maintenance, for regulatory purposes (testing chemicals for possi ble health effects), for industry and for biomonitoring. Various well-established genotoxicity testing assays are available; some have been approved under recommendations from the European Commission, the International Conference on Harmonisation (ICH - p harmaceutical industry) or OECD. No single test is sufficient, and all tests have significant limitations. The emphasis in EcoGenoTox will be on providing a battery of high throughput, sensitive, validated assays. Among them, the comet assay (single cell  gel electrophoresis) is particularly versatile as a method for measuring different kinds of DNA damage as well as DNA repair. 
The network, while based in Norway, will encompass scientists of international renown from institutions in Europe and beyond. Ex isting links with regulatory bodies and potential end-users will be consolidated. Full project meetings will be held at the beginning of the project to formulate network activities, and at the end to decide future plans. Video conferences will be arranged  at regular intervals to discuss specific points, as well as meetings of partners whenever necessary.
The network will co-ordinate inter-laboratory validation trials of existing and modified assays, in close co-operation with regulatory organisations.

Coordinated approach to improved environmental genotoxicity testing

The Society for Free Radical Research (Europe) and the European Environmental Mutagen Society independently decided to hold their annual meetings in Oslo, and asked Andrew Collins (University of Oslo) and Gunnar Brunborg (Norwegian Institute of Public Hea lth) to organise the meetings back-to-back. Since the societies have certain interests in common, we decided to hold a joint symposium, on DNA Repair, with several notable speakers. DNA repair is an area of biological research in which Norwegian teams hav e excelled, and so this is an excellent opportunity to 'showcase' some of the best of Norwegian science, to a wider audience of environmental and other scientists. The conferences will be held during the week of September 12 to 18, 2010, in the Oslo Congr ess Centre (Folkets hus). 
The objective of the Society for Free Radical Research (Europe; SFRR) is to advance education in free radical processes, for the benefit of the public. Free radicals are species that contain an unpaired electron, making them, in  general, highly reactive and damaging to other molecules, with considerable industrial, biological and medical implications. In addition to their importance for industrial processes such as the formation of polymers, they play important roles in atmosphe ric and photochemical processes, and are involved in essential biological processes such as cell death, mutagenesis and tumour growth.
The European Environmental Mutagen Society, EEMS, is organized and operated to encourage the study of mutagens and subst ances of related biological activity in the human environment, particularly those agents that may be of concern to public health. EEMS is engaged in and sponsor research and dissemination of relevant information. EEMS is a meeting place for scientists and  students, from a wide area comprising experimental toxicology, molecular biology, DNA repair, epidemiology, exotoxicology and regulatory toxicology.

0 antall prosjekter

PES2020-Prosj.etabl.støtte H2020

Innovative Training Network - DNA damage responses in Development and Disease, aDDRess

Tildelt: kr 56 999

Prosjektperiode: 2017-2018

Sted: Oslo

PES2020-Prosj.etabl.støtte H2020

High Throughput Estimation of DNA Repair Capability

Tildelt: kr 21 219

Prosjektperiode: 2014-2014

Sted: Oslo

PES-EUR-Prosjektetablererstøtte Eureka

A compact comet assay for versatile biomedical testing

Tildelt: kr 0,10 mill.

Prosjektperiode: 2013-2013

Sted: Oslo

PES-EU-Prosjektetablererstøtte EU (bedrift)

Novel and emerging contaminants in Europe: Sources, occurrence, fate and impact for humans and the environment.

Tildelt: kr 42 000

Prosjektperiode: 2013-2013

Sted: Oslo

IS-MOBIL-Mobilitetsprogr.f.utl.Ph.D-stu

Analysing DNA damage and repair in human population groups- Mobile researcher: Olena Bilyk, Ukraine

Tildelt: kr 0,11 mill.

Prosjektperiode: 2012-2013

Sted: Oslo

DIV-INT-Annet internasjonalt samarbeid

Coordinated approach to improved environmental genotoxicity testing

Tildelt: kr 0,60 mill.

Prosjektperiode: 2010-2011

Sted: Oslo

FRIBIO-Biologi og biomedisin

2010 meetings of SFRR and EEMS in Oslo

Tildelt: kr 0,20 mill.

Prosjektperiode: 2010-2010

Sted: Oslo

IS-RUS-Stipendprogram for NVRussl.

Collins, Andrew RUS04/05 pva 4 russiske forskere

Tildelt: kr 0,10 mill.

Prosjektperiode: 2004-2006

Sted: Oslo